Division of Clinical Pharmacology & Therapeutic Innovation, The Children's Mercy Hospital & Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA.
Pharmacogenomics. 2013 Jun;14(8):913-22. doi: 10.2217/pgs.13.66.
High-resolution melt (HRM) analysis using 'release-on-demand' dyes, such as EvaGreen(®) has the potential to resolve complex genotypes in situations where genotype interpretation is complicated by the presence of pseudogenes or allelic variants in close proximity to the locus of interest. We explored the utility of HRM to genotype a SNP (785A>G, K262R, rs2279343) that is located within exon 5 of the CYP2B6 gene, which contributes to the metabolism of a number of clinically used drugs. Testing of 785A>G is challenging, but crucial for accurate genotype determination. This SNP is part of multiple known CYP2B6 haplotypes and located in a region that is identical to CYP2B7, a nonfunctional pseudogene. Because small CYP2B6-specific PCR amplicons bracketing 785A>G cannot be generated, we simultaneously amplified both genes. A panel of 235 liver tissue DNAs and five Coriell samples were assessed. Eight CYP2B6/CYP2B7 diplotype combinations were found and a novel variant 769G>A (D257N) was discovered. The frequency of 785G corresponded to those reported for Caucasians and African-Americans. Assay performance was confirmed by CYP2B6 and/or CYP2B7 sequence analysis in a subset of samples, using a preamplified CYP2B6-specific long-range-PCR amplicon as HRM template. Inclusion rather than exclusion of a homologous pseudogene allowed us to devise a sensitive, reliable and affordable assay to test this CYP2B6 SNP. This assay design may be utilized to overcome the challenges and limitations of other methods. Owing to the flexibility of HRM, this assay design can easily be adapted to other gene loci of interest.
高分辨率熔解(HRM)分析使用“按需释放”染料,如 EvaGreen(®),具有在存在与感兴趣的基因座附近的假基因或等位基因变体的情况下解析复杂基因型的潜力。我们探索了 HRM 用于对 SNP(785A>G,K262R,rs2279343)进行基因分型的效用,该 SNP 位于 CYP2B6 基因的外显子 5 内,该基因参与了许多临床使用药物的代谢。785A>G 的测试具有挑战性,但对于准确的基因型确定至关重要。该 SNP 是多个已知 CYP2B6 单倍型的一部分,位于与非功能性假基因 CYP2B7 相同的区域。由于不能生成包含 785A>G 的小 CYP2B6 特异性 PCR 扩增子,因此我们同时扩增了这两个基因。评估了 235 个肝组织 DNA 和 5 个 Coriell 样本。发现了 8 种 CYP2B6/CYP2B7 二倍型组合,并发现了一种新的变体 769G>A(D257N)。785G 的频率与白人和非裔美国人的报道一致。使用作为 HRM 模板的预扩增 CYP2B6 特异性长程-PCR 扩增子,对一部分样本进行 CYP2B6 和/或 CYP2B7 序列分析,确认了分析性能。同源假基因的包含而不是排除使我们能够设计出一种敏感,可靠且经济实惠的检测该 CYP2B6 SNP 的方法。这种检测设计可以用于克服其他方法的挑战和局限性。由于 HRM 的灵活性,这种检测设计可以轻松适应其他感兴趣的基因座。